The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A phase II, open label, single arm study of nivolumab for recurrent or progressive IDH mutant gliomas with prior exposure to alkylating agents.
 
Eunji Yim
No Relationships to Disclose
 
Laura Donovan
Consulting or Advisory Role - Roon
 
Alicia Bargo
No Relationships to Disclose
 
Lakshmi Nayak
Honoraria - Ono Pharmaceutical
Consulting or Advisory Role - BraveBio; Genmab; Kite/Gilead; Ono Pharmaceutical
Speakers' Bureau - Ono Pharmaceutical
Research Funding - AstraZeneca (Inst); Kazia Therapeutics (Inst); Merck (Inst); Ono Pharmaceutical (Inst)
Patents, Royalties, Other Intellectual Property - Wolters Kluwer/ UpToDate, Inc- Royalty
Travel, Accommodations, Expenses - Ono Pharmaceutical
 
Yazmin Odia
Consulting or Advisory Role - GammaTile; Istari; PharPoint Research
Research Funding - Bristol-Myers Squibb (Inst); Novocure (Inst)
(OPTIONAL) Uncompensated Relationships - Actuate Therapeutics; Chimerix
 
Eric T. Wong
Honoraria - Novocure; UpToDate; Zai Lab
Consulting or Advisory Role - Turning Point Therapeutics
Research Funding - Imvax (Inst); Novocure (Inst); Oblato (Inst); Orbus Therapeutics (Inst)
 
Krystelle Pring
No Relationships to Disclose
 
Mervin Malig
No Relationships to Disclose
 
Yacha Genfi
No Relationships to Disclose
 
Nathaniel Wright
Employment - Icahn School of Medicine at Mount Sinai (I)
 
Lakshmi Kesari
No Relationships to Disclose
 
Alyssa Russ
No Relationships to Disclose
 
Kriti Bagri Manjrekar
No Relationships to Disclose
 
Denisse Torres
No Relationships to Disclose
 
Sarah Sta Ana
No Relationships to Disclose
 
Naomi Sender
No Relationships to Disclose
 
Suzanne Mistretta
Employment - Gilead Sciences (I)
Stock and Other Ownership Interests - Gilead Sciences (I)
 
Fabio Massaiti Iwamoto
Stock and Other Ownership Interests - Praesidia Biotherapeutics
Consulting or Advisory Role - Abbvie; Alexion Pharmaceuticals; Anheart Therapeutics; ClearView Healthcare Partners; Gennao Bio; Guidepoint Global; Kiyatec; Massive Bio; Medtronic; Merck; MimiVax; Novocure; Ono Pharmaceutical; PPD; Praesidia Biotherapeutics; Regeneron; tocagen; Xcures
Speakers' Bureau - Prime Oncology
Research Funding - ABM (Inst); Anheart Therapeutics (Inst); AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Celldex (Inst); FORMA Therapeutics (Inst); Merck (Inst); Northwest Biotherapeutics (Inst); Novocure (Inst); Pfizer (Inst); Sapience Therapeutics (Inst); tocagen (Inst)
Travel, Accommodations, Expenses - Oncoceutics
(OPTIONAL) Uncompensated Relationships - Northwest Biotherapeutics